Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.
about
P1343
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumorIdentification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts
P2860
Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Establishment and characteriza ...... ith loss of ARID1A expression.
@ast
Establishment and characteriza ...... ith loss of ARID1A expression.
@en
type
label
Establishment and characteriza ...... ith loss of ARID1A expression.
@ast
Establishment and characteriza ...... ith loss of ARID1A expression.
@en
prefLabel
Establishment and characteriza ...... ith loss of ARID1A expression.
@ast
Establishment and characteriza ...... ith loss of ARID1A expression.
@en
P2093
P2860
P1433
P1476
Establishment and characteriza ...... ith loss of ARID1A expression.
@en
P2093
Akiko Kudoh
Hiroaki Itamochi
Hiroaki Komatsu
Jun Chikumi
Michiko Nonaka
Muneaki Shimada
Seiya Sato
Shinya Sato
Tasuku Harada
P2860
P2888
P304
P356
10.1007/S13577-016-0138-6
P4510
P577
2016-03-09T00:00:00Z
P6179
1020345115